HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity
about
Principles of antibody-mediated TNF receptor activation4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesEnhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection.Therapeutic targeting of CD70 and CD27.Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.The growing impact of lyophilized cell-free protein expression systems.Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections.Ex vivo nicotine stimulation augments the efficacy of human peripheral blood mononuclear cell-derived dendritic cell vaccination via activating Akt-S6 pathway.
P2860
Q26796270-0CE96A6E-3B42-4785-8DA5-39250180B993Q27314155-33AAB5FC-A8CA-405B-8256-A6B7E95CB2B0Q33779343-11DF0229-4C46-497F-A585-9CE973497F5BQ38667053-1CA1427E-FF28-4B89-A441-1B61A76DF7AAQ38749841-0F8BA93A-BC7C-46A5-AE62-92019A379D1CQ38771001-2CE800BD-D265-4C3F-BA89-093D86177AE7Q40588780-A7C92572-E984-48D6-AFE6-88BE4952B857Q42536890-F1B69A74-28EE-4331-AFA1-9DBA278FB5C2Q50335281-39C0E32B-A2FF-41F2-A6E4-D5F312E1F957Q53352240-5A504260-DACB-4FB1-AD5F-B40DAC5CD6B9
P2860
HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@ast
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@en
type
label
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@ast
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@en
prefLabel
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@ast
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@en
P2093
P2860
P1433
P1476
HIV-1 adenoviral vector vaccin ...... l mediated anti-viral immunity
@en
P2093
Francesca N Raffa
Geoffrey W Stone
James M Termini
Katherine A Fuller
Sachin Gupta
Sakhi Philip
Saravana Kanagavelu
Yaelis Rivas
P2860
P304
P356
10.1371/JOURNAL.PONE.0090100
P407
P577
2014-02-28T00:00:00Z